We also use the mouse model to demonstrate that blockade of either CXCL1 or its receptors inhibits obesity-dependent ASC tumour trafficking and abrogates the obesity-associated promotion of tumour vascularization and growth. The gene discussed is CXCL1; the disease is neoplasm.